©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Chicken Oocytes and Somatic Cells Express Different Splice Variants of a Multifunctional Receptor (*)

(Received for publication, June 22, 1995)

Hideaki Bujo (§) Ken A. Lindstedt (¶) Marcela Hermann Lourdes Mola Dalmau (**) Johannes Nimpf Wolfgang J. Schneider (§§)

From the Department of Molecular Genetics, Biocenter and University of Vienna, Dr. Bohr-Gasse 9/2, A-1030 Vienna, Austria

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

An abundant 95-kDa protein belonging to the low density lipoprotein receptor supergene family is essential for chicken oocyte growth by mediating the uptake of multiple plasma-borne yolk precursors. This receptor harbors at the amino terminus a cluster of eight tandemly arranged repeats typical of the ligand binding domains of members of this family and is designated low density lipoprotein receptor relative with 8 repeats (LR8). Here, we demonstrate by reverse transcriptase-polymerase chain reaction, Northern, and Western blot analyses that the chicken expresses two forms of LR8, which are generated by differential splicing of an exon encoding a serine- and threonine-rich region characteristic of LRs, termed O-linked sugar domain. The female germ cell of the chicken expresses extremely high levels of the short form of LR8 (LR8-), i.e. the 95-kDa protein; in contrast, somatic cells express lower but detectable levels of the form containing the O-linked sugar domain (LR8+). The main sites of LR8+ expression in the chicken are the heart and skeletal muscle, i.e. the same tissues where LR8 mRNAs predominate in mammals; in addition, in situ hybridization demonstrates that a significant amount of LR8+ is produced in the hen's ovarian follicular granulosa cells. We found no apparent functional difference between the two receptor forms; however, cell type-specific targeting of the multiple ligands of these receptors possibly relates to their respective expression on the cell surface.


INTRODUCTION

Receptors belonging to the low density lipoprotein receptor (LDLR) (^1)supergene family play key roles in both systemic transport processes and oocyte growth in oviparous species (Schneider and Nimpf, 1993; Schneider, 1995). One of the recently characterized receptors in this group is a chicken protein whose established major functions are the transport of very low density lipoprotein (VLDL), vitellogenin, alpha(2)-macroglobulin, and lactoferrin into rapidly growing oocytes (Bujo et al., 1994, Jacobsen et al., 1995; Hiesberger et al., 1995). This chicken receptor, as well as its mammalian homologues (the so-called VLDL receptors), possesses in its ligand binding domain eight tandemly arranged complement-type repeats, each consisting of approximately 40 residues, that display a triple-disulfide bond-stabilized negatively charged surface. Receptors with eight ligand-binding repeats have been shown to interact with apolipoprotein (apo)B (George et al., 1987; Nimpf et al., 1988), apoE-rich VLDL and so-called beta-migrating VLDL (Hayashi et al., 1989; Takahashi et al., 1992; Sakai et al., 1994), and the 39-kDa receptor-associated protein (RAP) (Battey et al., 1994; Wiborg Simonsen et al., 1994; Hiesberger et al., 1995). Because this broad ligand specificity does not allow for unambiguous nomenclature based on ligand definition, we here designate them LDLR relatives with eight repeats, LR8 in short, to distinguish them from the classical LDLRs (LR7), which harbor a cluster of seven such repeats.

Analysis of the mutant ``restricted ovulator'' hen, characterized by lack of oocyte growth that results in severe hyperlipidemia and sterility (Ho et al., 1974; Jones et al., 1975), revealed that its oocytes neither express normal LR8 nor bind VLDL or vitellogenin (Nimpf et al., 1989; Stifani et al., 1990a). These results indicate that LR8 is essential for yolk lipoprotein deposition into oocytes, a key requirement for reproduction. In this context, the expression of LR8 in mammals is of interest. In contrast to the major site of expression in oviparous species, the ovary, mammalian LR8s are found in tissues with active metabolism of fatty acids, such as skeletal muscle, heart, adipose tissue, and brain (Takahashi et al., 1992; Gåfvels et al., 1993, 1994; Oka et al., 1994b; Webb et al., 1994; Jokinen et al., 1994). The chicken oocyte, on the other hand, avidly takes up yolk proteins including VLDL, not for immediate catabolism but rather for storage and later use as energy supply for the developing embryo.

Previously, we have identified by Northern blotting transcripts of a size similar to that of the oocyte LR8 in tissues of the chicken other than the ovary (Bujo et al., 1994). In particular, low levels of cross-reactive mRNA species were found in heart and skeletal muscle, i.e. the major sites of expression of mammalian LR8s (Takahashi et al., 1992; Gåfvels et al., 1993, 1994; Oka et al., 1994b; Webb et al., 1994; Jokinen et al., 1994). Mammalian LR8 transcripts exist in splice variant forms: the major form is a mRNA that contains an exon coding for the so-called clustered O-linked sugar domain, but mRNAs coding for LR8 lacking that domain have also been identified (Sakai et al., 1994; Webb et al., 1994; Jokinen et al., 1994). The sites of expression of the different forms in mammals have not been studied in detail. Since lack of the O-linked sugar domain is one of the characteristics of the well characterized chicken oocyte LR8, we considered the possibility that other somatic tissues of the chicken may produce low levels of a differently spliced LR8 transcript. Recently, in the course of studies on the mutation in LR8 causing the restricted ovulator phenotype, (^2)we have identified such a transcript because of its enhanced expression in mutant ovaries. Here, we demonstrate that chickens indeed produce these two differently spliced LR8 mRNAs, differing by 90 nucleotides, and the corresponding proteins in cell type-specific fashion. Interestingly, we could not detect a functional difference between the two receptor forms in vitro. However, since only rapidly growing oocytes express on their surface high levels of LR8 lacking the O-linked sugar domain, cell type-specific receptor production may be important for ligand targeting in vivo.


MATERIALS AND METHODS

RT-PCR Amplification of LR8 cDNA

Total RNA was extracted from adult (>6 months old) female chicken tissues, and poly(A)-RNA was isolated as described previously (Bujo et al., 1994). Single-stranded cDNA was synthesized from poly(A)-RNA using SuperScript reverse transcriptase (Life Technologies, Inc.) and random primers. Four oligonucleotides (P1, -2, -3, and -4) were synthesized for use as PCR primers: P1, 5`-CGACGGGATATCAGGAAGATTGGCC-3`; P2, 5`-AGGAAGAACAGCCCAAGCTCCTGCT-3`; P3, 5`-ACCCTAGTAAACAACCTCAATGATG-3`; and P4, 5`-TGGAGGAAGTCTTTCAGCCACAAGC-3`. The nucleotide sequences of the primers were corresponding to nucleotide numbers 1396-1420 (sense), 2358-2382 (antisense), 2098-2122 (sense), and 2656-2680 (antisense) of chicken LR8- (see Fig. 1A). One-fourth of the synthesized cDNA was used for subsequent PCR amplifications. These were performed with the three pairs of primers, P1/P2, P3/P4, or P3/P2, respectively, using the GeneAmp PCR kit (Perkin-Elmer) on a Perkin-Elmer Thermal Cycler 480. PCR parameters were 94 °C for 1 min, 60 °C for 1 min, and 72 °C for 2 min for 30 cycles. The amplified products were subjected to agarose gel electrophoresis and stained with ethidium bromide. The resulting amplified fragments were subcloned into the pGEM-T vector (Promega), and several clones from each fragment were isolated and sequenced using Sequenase (U. S. Biochemical Corp.).


Figure 1: Identification of the splice variant forms of chicken LR8. A, schematic representation of chicken oocyte LR8-. The signal sequence (SS) and the following domains are shown: eight binding repeats in the ligand binding domain; the cysteine-rich repeats A, B, and C in the epidermal growth factor precursor homology domain; transmembrane domain (TM); and the cytoplasmic domain (Cyto.). Nucleotide (nt) and amino acid (a.a.) numbers (Bujo et al., 1994) are shown below and above the schematic representation, respectively. The primers P1-P4 (shortarrows) used for PCR amplification and the sizes of amplified fragments as expected from LR8- are indicated. The region of the cDNA covered by the probes used for Northern blot analysis, corresponding to the region common to LR8- and LR8+, is shown by a boldline (nucleotide number -12 to 1881). B, PCR-amplified products separated on a 1.0% agarose gel. The pair P3/P4 was used to amplify cDNA from pooled follicles (0.2-2.0 cm in diameter) as described under ``Materials and Methods.'' The main fragment of expected size (583 nucleotides, see A) and the additional longer fragment are indicated by closed and openarrowheads, respectively. The 100-Base Pair Ladder (Pharmacia) was used as size marker. C, alignment of O-linked sugar domains of LR8+ from the chicken, the rat (Jokinen et al., 1994), the mouse (Gåfvels et al., 1994), the rabbit (Takahashi et al., 1992), and man (Gåfvels et al., 1993; Sakai et al., 1994; Webb et al., 1994). Alignment was performed by the GeneWorks computer program (IntelliGenetics Inc.), and gaps were introduced to optimize alignment. The additional 30-amino acid sequence in chicken LR8+ (openarrowheads) between residues 726 and 727 of LR8- (closedarrowheads) is shown. Serine and threonine residues in the chicken protein are emphasized by asterisksabove the aligned sequences, and identical residues in all proteins are indicated by darkshading.



Northern Blot Analysis of LR8 mRNA

Poly(A)-RNA prepared from various chicken tissues was denatured using glyoxal dimethyl sulfoxide, separated by electrophoresis on agarose gels, and blotted onto Hybond C Extra membranes (Amersham) using standard methods (Sambrook et al., 1989). Two independent cDNA probes for hybridization were prepared: 1) a mixture of two cDNA fragments covering the whole ligand binding domain and part of the epidermal growth factor precursor homology domain of chicken LR8 as previously described (Bujo et al., 1994) (see Fig. 1A) and 2) a 90-bp fragment corresponding to the entire sequence of the O-linked sugar domain found in the alternate form of chicken LR8 described here (see Fig. 1C). To prepare the 90-bp fragment as a probe, two oligonucleotides were synthesized: OSKF, 5`-TTTCAGGTACTGGAACAACTGTGGCTTACACTGAGGCTAAAGATACCAGC-3`, and OSKR, 5`-CTCCAGGAACTAGTCCAACAGTTGGAGATTTTTCAGTTGTGCTGGTATCT-3`. These sequences are corresponding to 50 bp of the 5`-side (sense) and the 3`-side (antisense) of the 90-bp fragment, respectively. The two oligonucleotides were annealed, and the resulting DNA fragment was labeled with P using the Klenow fragment of DNA polymerase (Sambrook et al., 1989). Northern blot analysis was performed as previously described (Bujo et al., 1994). Membranes were exposed to Fuji RX film with intensifying screens.

Western and Ligand Blot Analysis of LR8

Membrane fractions of the indicated tissues from adult chickens were prepared as previously described (Bujo et al., 1994). Samples were applied without heating or adding dithiothreitol (non-reducing conditions) to 4.5-18% gradient SDS-polyacrylamide gels according to Laemmli(1970). Electrophoresis, transfer to nitrocellulose membranes, and immunodetection were performed as previously described (Bujo et al., 1994). The rabbit IgG used for immunological analysis was prepared against a synthetic peptide corresponding to the last 14 amino acids of the deduced amino acid sequence of chicken LR8 (Bujo et al., 1994). Immunoblots were exposed to Hyperfilm-ECL (Amersham) for 10 s. In preparation for ligand blots, nonspecific binding sites were blocked by incubating the membrane overnight at +4 °C in buffer A (90 mM NaCl, 20 mM Tris, pH 7.4, 2 mM CaCl(2)) containing 5% bovine serum albumin (BSA). Incubations with ligand were for 2 h at 23 °C with I-labeled RAP (Hiesberger et al., 1995) (250 cpm/ng; 1 times 10^6 cpm/ml) in buffer A containing 5% BSA. The membrane was then washed extensively with buffer A containing 1% BSA, dried, and subjected to autoradiography using Reflection film (DuPont NEN) with intensifying screens at -80 °C for the times indicated.

In Situ Hybridization

Follicles from the ovaries of adult hens were dissected in ice-cold PBS, embedded in Tissue-Tek OCT compound (Miles) and immediately frozen with 2-methylbutane precooled in liquid nitrogen. Cryostat sections of 10-µm thickness were prepared, freeze-thawed onto glass slides pretreated with 2% 3-aminopropyltriethoxysilane, and stored at -70 °C. For in situ hybridization, the sections were dried, washed twice with PBS for 5 min each, and treated with 1 µg/ml proteinase K for 5 min at 37 °C. The slides were washed twice with PBS for 3 min, treated with 50 mM triethanolamine and 0.2% acetic anhydride in PBS for 2 min at 23 °C, and then washed twice for 2 min in 2 times SSC (Sambrook et al., 1989). Prehybridization was then carried out for 5 h at room temperature in a solution containing 5 times SSC, 0.1% SDS, 2% Denhardt's solution, 250 µg/ml salmon sperm DNA, 250 µg/ml tRNA, and 50% formamide. Digoxigenin-labeled antisense or sense RNA probes against the O-linked sugar region were prepared as follows. First, cDNA was prepared from heart mRNA by RT-PCR using two primers, 5`-TTTCAGGTACTGGAACAA-3` and 5`-CTCCAGGAACTAGTCCAA-3`, annealing to the ends of the 90 nucleotides coding for the O-linked sugar domain. The amplified 90-nucleotide fragment was then separated on a 1.5% agarose gel, purified using the QIAEX DNA gel extraction kit (QIAGEN), and subcloned into the pGEM-T vector. The purified plasmids were then linearized for run-off RNA polymerase transcription in both directions with the DIG RNA labeling kit (SP6/T7, Boehringer Mannheim, no. 1175 025). Hybridization was performed overnight at 45 °C with prehybridization solution containing 10% dextran sulfate and 300 ng/ml of the sense or antisense RNAs, and the slides were washed 3 times 10 min with 0.2 times SSC and 2 times 10 min with 0.1 times SSC at 50 °C. The following operations were performed at 23 °C. The slides were prepared for immundetection by incubation in 150 mM NaCl, 100 mM Tris-HCl, pH 7.5 (buffer B), containing 3% normal goat serum and 1% BSA for 30 min, then exposed to anti-DIG-alkaline phosphatase Fab fragments (1:1000 dilution) in the same buffer for 2 h, and extensively washed first with buffer B and then with 100 mM NaCl, 100 mM Tris-HCl, 50 mM MgCl(2), pH 9.5. The alkaline phosphatase-tagged antibody was then detected by incubating the slides overnight with a precipitating purple alkaline phosphatase substrate (Boehringer Mannheim, no. 1442 074). The reaction was stopped by incubating the slides in 10 mM Tris, 1 mM EDTA, pH 8.0, and mounting them in Aquamount (BDH, Poole). Photographs were taken with a Zeiss Axiovert 10 light microscope.


RESULTS

Molecular Characterization of Splice Variant Forms of Chicken LR8

To test in chicken for the expression of splice variants of LR8 possibly including the O-linked sugar domain, RT-PCR was performed with two pairs of oligonucleotide primers. These (P1/P2, and P3/P4 in Fig. 1A) encompassed the region corresponding to the alternative splice site in human LR8 (Sakai et al., 1994; Webb et al., 1994). The products amplified with the primer pair P3/P4 from ovarian cDNA showed, in addition to the expected 583-bp band, a larger and much less abundant band (Fig. 1B, filled and openarrows, respectively). Sequence analysis of the amplified fragments revealed that the unexpected larger product contained an insert of 90 nucleotides^2 between positions 2311 and 2312 of the previously characterized LR8- cDNA, corresponding to a site between the epidermal growth factor precursor homology and transmembrane domains of LR8 (amino acid residues 726/727) (Bujo et al., 1994). As shown in Fig. 1C, the deduced amino acid sequence of the 90-bp insert revealed that 11 of the encoded 30 amino acids were serine and threonine residues, typical of the O-linked sugar domains (Schneider, 1989) in LR8+ proteins of rat, mouse, rabbit, and man. This indicates that LR8 mRNA coding for an O-linked sugar domain is not only expressed in mammals (Takahashi et al., 1992; Gåfvels et al., 1993, 1994; Sakai et al., 1994; Oka et al., 1994a, 1994b; Webb et al., 1994; Jokinen et al., 1994) but also in the chicken. Alignment with the known O-linked sugar domains of mammalian LR8s showed extensive identity with rabbit (70%) (Takahashi et al., 1992), human (67% according to Gåfvels et al.(1993), Sakai et al.(1994), and Webb et al.(1994); 63% according to Oka et al. (1994a)), mouse (57% according to Gåfvels et al.(1994); 53% according to Oka et al. (1994b)), and rat (53%) (Jokinen et al., 1994), respectively. In the following, LR8 lacking the O-linked sugar domain is designated LR8-, and the longer form is designated LR8+.

Expression of Splice Variant mRNAs

We have already shown that chicken LR8- is the predominant, if not the only, form of the receptor present in oocytes (Nimpf et al., 1989; Barber et al., 1991; Bujo et al., 1994). However, Northern blot analysis revealed that muscle and heart, and possibly the ovary, express very low levels (0.5-1% of LR8- in the ovary) of a cross-reactive slightly larger mRNA (Bujo et al., 1994). In this context, in rabbit, mouse, and rat, LR8 mRNAs are abundant in heart, muscle, adipose tissue, and brain (Takahashi et al., 1992; Gåfvels et al., 1994; Oka et al., 1994b; Jokinen et al., 1994), and human receptor transcripts (Gåfvels et al., 1993; Webb et al., 1994) and rat protein (Jokinen et al., 1994) were reported to be expressed at high levels in ovary, heart, and muscle. However, it has not been determined which of the variant forms contribute to expression in the individual tissues. Our previous studies at the protein level (George et al., 1987; Hayashi et al., 1989; Barber et al., 1991; Bujo et al., 1994), which suggested exclusive expression of chicken LR8 in growing oocytes and did not demonstrate receptor variants, prompted us to reconcile these findings, particularly with those in mammals. At the same time, we wanted to determine the exact cellular distribution of LR8 splice variants.

Thus, we performed RT-PCR and Northern blot analysis of transcripts in different chicken tissues. PCR with the primer pair P3/P2 (cf. Fig. 1A) showed that the relative levels of expression in ovary, muscle, and heart of the variants described in Fig. 1were significantly different (Fig. 2). The product corresponding to the amplified region in LR8+ (openarrow, of the expected size (375 bp)) predominates in muscle and heart (lanes2 and 3) in distinct contrast to the ovary, where LR8- (closedarrow, product of the expected size (285 bp)) is by far the major form. In fact, the ratios of intensities of the two amplified fragments (LR8-/LR8+) were similar in muscle and heart but opposite to that in ovary. These results indicate that the splice variants are expressed at vastly different levels in these major sites of LR8 expression in the chicken. Only very few, if any, RT-PCR amplifiable transcripts were found in brain, kidney, and liver (data not shown; see below).


Figure 2: Tissue-dependent expression of splice variants of LR8. mRNA from ovary (lanes1 and 4), muscle (lanes2 and 5), and heart (lanes3 and 6) were used for cDNA synthesis with (lanes1-3) or without (lanes4-6) reverse transcriptase for PCR. Amplified products using the primer pair P3/P2 (see Fig. 1A) were separated on a 1.5% agarose gel. The different splice forms, with or without O-linked sugar domain, are indicated by open and closedarrowheads, respectively. The size marker is a 100-Base Pair Ladder (Pharmacia).



To obtain further evidence for the production of differently spliced transcripts, we next directly identified LR8- and LR8+ mRNAs in chicken tissues by Northern blot analysis. Previously, chicken LR8 transcripts in ovary, heart, and muscle have been shown, with probes corresponding to regions outside the O-linked domain, to have a size of 3.5 kb (Bujo et al., 1994). However, the current results suggest that these 3.5-kb signals might actually represent both splice variant forms of chicken LR8. Therefore, we analyzed the original Northern blot with the 90-bp probe specifying exactly the O-linked sugar domain in chicken LR8+. With this probe, an expression pattern very different from that obtained with the probe corresponding to the common domains (Bujo et al., 1994) was obtained (Fig. 3). Under these conditions, the 3.5-kb signal, representing exclusively LR8+ transcripts, was detected only in muscle and heart but not in the ovary (upon prolonged exposure, there was a faint signal in ovary). These results reveal that there exist two forms of LR8 mRNA in the chicken, characterized by possessing or lacking a region coding for an O-linked sugar domain, and that their relative levels of expression vary greatly among different tissues and/or cells.


Figure 3: Identification of splice variants of LR8 mRNA by Northern blotting. Hybridization was performed with the 90-bp probe specific for the O-linked sugar domain of chicken LR8+. Lane1, ovary; lane2, heart; lane3, muscle; lane 4, brain; lane 5, liver; lane 6, adrenal gland; lane 7, spleen; lane 8, lung; lane 9, kidney; and lane 10, small intestine. Autoradiography was at -70 °C for 7 days with intensifying screens.



Variant Transcripts and Their Protein Products Are Expressed in Cell Type-specific Fashion

Next, we wanted to identify the protein products of the two LR8 transcripts. We have already shown that the cloned oocyte LR8 cDNA specifies a 95-kDa protein, characterized its ligand binding functions, and established its localization in oocytes (George et al., 1987; Nimpf et al., 1989; Steyrer et al., 1990; Barber et al., 1991; Shen et al., 1993; Bujo et al., 1994; Jacobsen et al., 1995; Hiesberger et al., 1995). Here, based on the results of RT-PCR and Northern blotting, we used an antibody directed against the C-terminal 14 residues of the receptor, which are common to LR8- and LR8+, to analyze the immunoreactive proteins in hearts of roosters and laying hens, and in ovarian follicles (Fig. 4). In the follicles, a very strong 95-kDa band was visualized in only 0.2 µg of total protein (lane1, filledarrow). In both heart samples (lanes2 and 3), a very weak band, visible only upon analysis of at least 100-fold more protein than of follicle extract, comigrated with the major follicle protein, and a stronger band migrated slower (openarrow, approximate M(r), 105,000). Taken together with the above results at the transcriptional level, these data lead us to conclude that the two immunoreactive proteins represent the splice variant forms of chicken LR8.


Figure 4: Immunological identification of the splice variant forms of LR8 protein. Membrane extracts of ovarian follicles (0.2 µg, lane1), heart from laying hen (35 µg, lane2), and heart from rooster (35 µg, lane3) were subjected to 4.5-18% SDS-polyacrylamide gel electrophoresis under non-reducing conditions and processed for immunoblotting with the IgG directed against a C-terminal peptide of chicken LR8 as described under ``Materials and Methods.'' The signals corresponding to LR8- (the previously described 95-kDa protein) (Bujo et al., 1994) and to LR8+ are indicated by closed and openarrowheads, respectively. Exposure was for 10 s on Hyperfilm-ECL.



To gain insight into possible functional differences between the two receptor forms, we expressed them in heterologous somatic cell systems (for the expression of LR8-, cf. Bujo et al. (1994) and Jacobsen et al.(1995)) and attempted to study their properties in cell surface binding studies. However, we consistently observed vastly different degrees of surface expression of the two forms, rendering such an approach inappropriate. Furthermore, the very low expression of LR8+ in tissues (cf. Fig. 4) precluded analysis by binding studies with physiological ligands. However, we already know that the best characterized non-lipoprotein ligand of the LR family, i.e. RAP, binds to LR8- with higher affinity than lipoproteins (Hiesberger et al., 1995). Thus, having identified the heart as a site of co-expression of LR8- and LR8+, we used I-RAP in ligand blots (Fig. 5) on extracts from this tissue; follicle extract served as positive control for the binding of RAP to LR8-. Clearly, LR8+ binds RAP as well; importantly, the ratio of intensities of the bands visualized via binding of I-RAP (Fig. 5) and I-VLDL (not shown) is equal to that detected by Western blotting (Fig. 4) or at the transcript level ( Fig. 2and Fig. 3).


Figure 5: Binding of I-RAP to both LR8 splice variants. Chicken ovarian follicle membrane extract (lane1) and laying hen heart extract (lane2) were subjected to SDS-polyacrylamide gel electrophoresis and ligand blot analysis using I-labeled RAP as described under ``Materials and Methods.'' The binding of I-RAP to LR8+ (openarrowhead) and LR8- (closedarrowhead) was visualized by autoradiography for 24 h. Numbers on the left correspond to the molecular masses (kDa) of marker proteins.



The major site of expression of chicken LR8- is the growing oocyte (George et al., 1987; Hayashi et al., 1989; Barber et al., 1991; Shen et al., 1993; Bujo et al., 1994). Interestingly, previous in situ hybridization analysis of ovarian sections showed that receptor mRNA is concentrated in a narrow zone underlying the plasma membrane of vitellogenic oocytes (Bujo et al., 1994). The ovarian follicle preparations analyzed routinely consist of the giant oocyte as well as somatic cells, in particular granulosa cells and theca cells that surround the oocyte. To determine whether the small amount of LR8+ transcript detected in follicles ( Fig. 2and Fig. 3) was derived from any or all of the somatic cells, we performed the following experiments ( Fig. 6and Fig. 7). For analysis of cell-specific mRNAs, the follicle was mechanically dissected (Gilbert et al., 1977) to isolate the granulosa cell monolayer (lanes1) and the thecal cells (lanes2). We also analyzed mRNA isolated from undissected follicles containing oocytes at different growth stages (lanes3 and 4). The mRNAs were hybridized with the probes reacting with both LR8 transcripts or with the O-linked sugar domain-specific probe, respectively. The results of Fig. 6demonstrate that granulosa cells, as well as follicles (both 0.3 and 2 cm in diameter), contain detectable levels of LR8 transcripts; the oocyte-containing follicles clearly express high levels of LR8-, and the somatic cells express LR8+.


Figure 6: Localization of splice variant forms of the LR8 mRNA in chicken ovarian follicles. 2 µg of poly(A)-RNA isolated from granulosa cell sheets (lane1), the connective tissue surrounding the follicles (thecal layers) (lane2), and from two undissected follicles containing oocytes of different sizes (lane3, 0.3 cm, and lane4, 2 cm in diameter) were used for Northern blot analysis on a 1.0% agarose gel. Hybridization was performed as described in Fig. 3B. The left and rightpanels show the results of hybridization with the probes corresponding to the common region (see Fig. 1A) and the probe specific for the O-linked sugar domain, respectively. -DNA digested by HindIII was used as size marker (in kb). Exposure time was 6 h for the leftpanel and 5 days for the rightpanel, with intensifying screens.




Figure 7: Localization in a chicken follicle of the LR8+ mRNA. Cryostat sections of a chicken follicle (diameter, 6 mm) were subjected to in situ hybridization with an antisense (A) and a sense (B) digoxigenin-labeled RNA probe corresponding to the O-linked sugar domain of LR8+. The hybridized probe was visualized using alkaline phosphatase-coupled goat anti-digoxigenin IgG as described under ``Materials and Methods.'' The horizontal cell layer, distinctively stained in the middle part of panelA, represents the granulosa cells (g), which separate the theca cell layer (t) from the oocyteproper (o). Bar, 10 µm.



Since granulosa cells are present in the follicle preparations (see above), these results suggested that the minute amounts of LR8+ transcript seen in lanes3 and 4, rightpanel (better visualized by prolonged exposure), are derived from these somatic cells. Direct evidence for exclusive expression of LR8+ in granulosa cells was obtained by in situ hybridization analysis of a vitellogenic follicle (Fig. 7). To this end, we used a 90-nucleotide probe corresponding exactly to the O-linked sugar domain in LR8+; the oocyte showed no reactivity with this probe. These findings are in accordance with our previous conclusion (George et al., 1987; Hayashi et al., 1989; Barber et al., 1991; Shen et al., 1993; Bujo et al., 1994) that within the follicle, it is the female germ cell that expresses LR8-.


DISCUSSION

LDL receptor family members containing a single cluster of eight complement-type repeats co-exist with other relatives in the same organism (Takahashi et al., 1992; Gåfvels et al., 1993, 1994; Sakai et al., 1994; Oka et al., 1994a, 1994b; Webb et al., 1994; Bujo et al., 1994; Jokinen et al., 1994). Of particular interest is the emerging notion that such co-expression cannot be required because of exclusive ligand recognition by these receptors (Brown and Goldstein, 1986; Strickland et al., 1990, 1991; Beisiegel et al., 1991; Herz et al., 1991; Stifani et al., 1990b; Bu et al., 1992; Chappell et al., 1992; Huettinger et al., 1992; Orth et al., 1992; Willnow et al., 1992; Kounnas et al., 1992, 1993; Nykjaer et al., 1992, 1993; Battey et al., 1994; Fischer et al., 1993; Hofer et al., 1994; Wiborg Simonsen et al., 1994; Schneider, 1995). In fact, several ligands, such as apoE, beta-migrating VLDL, and RAP are ligands for all, and others, such as LDL and chylomicron remnants, for more than one of the known members of the family. The family thus far includes the classical LDLR, the so-called VLDL receptor, and the ambiguously named LDLR-related protein/alpha(2)-macroglobulin receptor(s) (LRP/alpha(2)MR) as well as glycoprotein 330/megalin (Saito et al., 1994). We feel that the extensively overlapping and currently poorly understood ligand recognition spectra of these receptors preclude a useful nomenclature based on ligand designation; rather, we suggest to use the distinct structural features of these molecules (in particular the number of complement-type repeats) for their identification. Thus, here we designate these LDLR relatives (LRs) as LR7 and LR8 and propose the designations LR31 to LR36 for the large members of the family.

Mammalian LR8s are most abundantly expressed in heart, skeletal muscle, brain, and adipose tissue, but not in liver, one of the the major sites of expression of LR7 and LR31 (Takahashi et al., 1992; Gåfvels et al., 1993, 1994; Oka et al., 1994b; Webb et al., 1994; Jokinen et al., 1994). Recently, it has been reported that the human ovary also expresses LR8 (Webb et al., 1994); this is of potential significance in the light of our finding that in the chicken, LR8 expression is by far the highest in oocytes (George et al.(1987); Hayashi et al.(1989); Barber et al.(1991); Shen et al.(1993); Bujo et al.(1994) and present data).

We have now discovered that those tissues which express LR8 in mammals also express this receptor in chicken, albeit at very low levels compared to the oocytes. In the chicken, the role of LR8 as an important mediator of oocyte growth via yolk deposition has been established both by biochemical and genetic evidence (George et al., 1987; Nimpf et al., 1989; Barber et al., 1991; Stifani et al., 1990b; Shen et al., 1993). However, in mammals neither the function nor the exact site of expression of LR8 in the ovary is known.

One difference in the structures of the major LR8s in mammals and the chicken oocyte LR8, i.e. the presence and absence of the O-linked sugar domain, respectively, prompted us to investigate in detail the expression of LR8 splice variants in the egg-laying animal. The results strongly suggest that somatic cells and tissues, in particular granulosa cells, heart, and skeletal muscle express predominantly LR8+, while the oocyte is by far the major site of LR8- expression. In the context of findings in the rat (Jokinen et al., 1994), which are compatible with a role of LR8 other than in lipoprotein metabolism, we interpret the results in the laying hen as follows. Oocytic LR8- is a multifunctional receptor, which transports lipoproteins and other components (Mac Lachlan et al., 1994; Jacobsen et al., 1995) required for embryonic growth; with the exception of unique yolk precursors, this may hold true for other tissues, including the mammalian ovary. However, a definitive answer to the physiological role of LR8- in mammals cannot be provided at present. LR8+, on the other hand, is likely to perform similar functions in mammals and oviparous species, as they express this receptor in the same tissues. Again, a physiological role of LR8+, not directly related to the transport of lipoproteins, has been suggested (Jokinen et al., 1994).

It is noteworthy that for rat and mouse LR8+, possible alternative splicing outside the region considered here has been discovered during cloning studies (Gåfvels et al., 1994; Jokinen et al., 1994). Northern blot analysis in rabbit, rat, mouse, and human tissues revealed, in addition to the transcripts corresponding to LR8-/LR8+, transcripts of 9.5 kb in rabbit (Takahashi et al., 1992), 9.1 kb in rat (Jokinen et al., 1994), 4.5 and 7.9 kb (Oka et al., 1994b) or 8 kb (Gåfvels et al., 1994) in mouse, and 6.0 kb (Gåfvels et al., 1993) or 5.2 kb (Webb et al., 1994) in human. The exact nature of these transcripts has not been delineated; in rats, all transcripts are coordinately regulated in response to changes in the thyroid status (Jokinen et al., 1994). We have not detected any other but the 3.5-kb LR8 transcripts in the chicken.

In the light of our limited knowledge of the true physiological ligand(s) of LR8s, we can only speculate about the functional role of their O-linked sugar domain. In this context, preliminary experiments indicate that LR8- expressed in COS-7 or LR7-negative Chinese hamster ovary cells leads to detectable but poor surface activity (Bujo et al., 1994), while LR8+ is much more efficiently presented at the cell surface (data not shown). (^3)Thus, due to the very low levels of LR8+ protein in tissues, and as a result of these vastly different levels of surface expression of LR8+ versus LR8- in transfected cells, we could only analyze binding of the ligand with the highest affinity for the receptors (Fig. 5). Based on current results, we consider it unlikely, but nevertheless possible, that the ligand specificities of the two variant receptors differ sufficiently to direct different ligands to oocytes and somatic cells, respectively. Rather, it appears that regulation of surface expression of the variants in different cells or tissues holds the key to ligand targeting (Schneider, 1995). In strong support of this notion, deletion of the O-linked sugar domain in LR7, which is associated with very poor surface expression, brings about the clinical symptoms of familial hypercholesterolemia (Kajinami et al., 1988; Koivisto et al., 1992, 1993) despite unaltered ligand recognition by the mutant protein in vitro (Davis et al., 1986). We postulate that the chicken's female germ cell has specific means to express high levels of LR8- on the cell surface (George et al., 1987; Barber et al., 1991), and that this might be a regulatory mechanism for initiating oocyte growth. Namely, in situ hybridization studies (Bujo et al., 1994) and electron microscopical immunocytochemistry (Shen et al., 1993) have shown that LR8- mRNA and protein are present throughout the cytoplasm of previtellogenic oocytes. Upon onset of oocyte growth, mRNA becomes localized to the periphery, and the receptor is translocated to the plasma membrane (Shen et al., 1993), where it initiates and maintains oocyte growth through yolk precursor uptake. This translocation event could be a control site for tight regulation of oocyte growth and may require oocyte-specific mechanism(s) and protein factor(s). The absence of such mechanism or its activation in COS-7 and Chinese hamster ovary cells would explain the poor surface expression of LR8- in these cells. We also do not know whether LR8- in muscle and heart (Fig. 4) do reach the cell surface. LR8+ of somatic granulosa cells, which surround the oocytes during all phases from quiescence to rapid growth, may provide these cells with important substrates for their own sustenance and/or production of oocyte-directed regulatory signals. Current efforts are directed toward identification of these signals to possibly delineate their precursors, among them physiological ligands of LR8+. These considerations imply that ovarian LR8- and LR8+ cooperate to regulate and support normal oocyte growth and maturation. Detailed understanding of this synergism in the follicle may identify principles and functions of LR8s that are equally applicable to mammalian physiology.


FOOTNOTES

*
These studies were made possible by Austrian Science Foundation Grants FWF SP-07108 (to W. J. S.) and SP-07105 (to J. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Supported by a Lise Meitner Postdoctoral Fellowship of the Austrian Science Foundation (FWF M-004).

Held a Research Scholarship of the Austrian Ministry of Science, Research, and Art via The Austrian Academic Exchange Service (ÖAD).

**
Held a Research Stipend (North-South Dialogue Program) from the ÖAD.

§§
To whom correspondence should be addressed. Tel.: 43-1-79515-2113 or 43-1-79515-2115; Fax: 43-1-79515-2013 or 43-1-798-6224; wjs{at}mol.univie.ac.at.

(^1)
The abbreviations used are: LDLR, low density lipoprotein receptor, VLDL, very low density lipoprotein; LR8, LDLR relative with eight binding repeats; RT-PCR, reverse transcriptase-polymerase chain reaction; RAP, receptor-associated protein; apo, apolipoprotein; BSA, bovine serum albumin; bp, base pair(s); PBS, phosphate-buffered saline; kb, kilobase(s).

(^2)
H. Bujo, T. Yamamoto, K. Hayashi, M. Hermann, J. Nimpf, and W. J. Schneider, unpublished observations.

(^3)
T. Yamamoto, personal communication.


ACKNOWLEDGEMENTS

We appreciate the expert technical assistance by Martin Blaschek, Romana Kukina, and Michelle Mahon.


REFERENCES

  1. Barber, D. L., Sanders, E. J., Aebersold, R., and Schneider, W. J. (1991) J. Biol. Chem. 266,18761-18770 [Abstract/Free Full Text]
  2. Battey, F. D., Gåfvels, M. E., FitzGerald, D. J., Argraves, W. S., Chappell, D. A., Strauss, J. F., III, and Strickland, D. K. (1994) J. Biol. Chem. 269,23268-23273 [Abstract/Free Full Text]
  3. Beisiegel, U., Weber, W., and Bengtsson-Olivecrona, G. (1991) Proc. Natl. Acad. Sci. U. S. A. 88,8342-8346 [Abstract]
  4. Brown, M. S., and Goldstein, J. L. (1986) Science 232,34-47 [Medline] [Order article via Infotrieve]
  5. Bu, G., Williams, S. E., Strickland, D. K., and Schwartz, A. L. (1992) Proc. Natl. Acad. Sci. U. S. A. 89,7427-7431 [Abstract]
  6. Bujo, H., Hermann, M., Kaderli, M. O., Jacobsen, L., Sugawara, S., Nimpf, J., Yamamoto, T., and Schneider, W. J. (1994) EMBO J. 13,5165-5175 [Abstract]
  7. Chappell, D. A., Fry, G. L., Waknitz, M. A., Iverius, P.-H., Williams, S. E., and Strickland, D. K. (1992) J. Biol. Chem. 267,25764-25767 [Abstract/Free Full Text]
  8. Davis, C. G., Elhammer, A., Russell, D. W., Schneider, W. J., Kornfeld, S., Brown, M. S., and Goldstein, J. L. (1986) J. Biol. Chem. 261,2828-2838 [Abstract/Free Full Text]
  9. Fischer, D. G., Tal, N., Novick, D., Barak, S., and Rubinstein, M. (1993) Science 262,250-253 [Medline] [Order article via Infotrieve]
  10. Gåfvels, M. E., Caird, M., Britt, D., Jackson, C. L., Patterson, D., and Strauss, J. F., III (1993) Somat. Cell Mol. Genet. 19,557-569 [Medline] [Order article via Infotrieve]
  11. Gåfvels, M. E., Paavola, L. G., Boyd, C. O., Nolan, P. M., Wittmaack, F., Chawla, A., Lazar, M. A., Bucan, M., Caird, M., Angelin, B., and Strauss, J. F., III (1994) Endocrinology 135,387-394 [Abstract]
  12. George, R., Barber, D. L., and Schneider, W. J. (1987) J. Biol. Chem. 262,16838-16847 [Abstract/Free Full Text]
  13. Gilbert, A. B., Evans, A. J., Perry, M. M., and Davidson, M. H. (1977) J. Reprod. Fertil. 50,179-181 [CrossRef][Medline] [Order article via Infotrieve]
  14. Hayashi, K., Nimpf, J., and Schneider, W. J. (1989) J. Biol. Chem. 264,3131-3139 [Abstract/Free Full Text]
  15. Herz, J., Goldstein, J. L., Strickland, D. K., Ho, Y. K., and Brown, M. S. (1991) J. Biol. Chem. 266,21232-21238 [Abstract/Free Full Text]
  16. Hiesberger, T., Hermann, M., Jacobsen, L., Novak, S., Hodits, R. A., Bujo, H., Meilinger, M., Hüttinger, M., Schneider, W. J., and Nimpf, J. (1995) J. Biol. Chem. 270,18219-18226 [Abstract/Free Full Text]
  17. Ho, K.-J., Lawrence, W. D., Lewis, L. A., Liu, B. L., and Taylor, C. B. (1974) Arch. Pathol. 98,161-172 [Medline] [Order article via Infotrieve]
  18. Hofer, F., Gruenberger, M., Kowalski, H., Machat, H., Huettinger, M., Kuechler, E., and Blaas, D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91,1839-1842 [Abstract]
  19. Huettinger, M., Retzek, H., Hermann, M., and Goldenberg, H. (1992) J. Biol. Chem. 267,18551-18557 [Abstract/Free Full Text]
  20. Jacobsen, L., Hermann, M., Vieira, P. M., Schneider, W. J., and Nimpf, J. (1995) J. Biol. Chem. 270,6468-6475 [Abstract/Free Full Text]
  21. Jokinen, E. V., Landschulz, K. T., Wyne, K. L., Ho, Y. K., Frykman, P. K., and Hobbs, H. H. (1994) J. Biol. Chem. 269,26411-26418 [Abstract/Free Full Text]
  22. Jones, D. G., Briles, W. E., and Schjeide, O. A. (1975) Poultry Sci. 54,1780-1783
  23. Kajinami, K., Mabuchi, H., Itoh, H., Michishita, I., Takeda, M., Wakasugi, T., Koizumi, J., and Takeda, R. (1988) Arteriosclerosis 8,187-192 [Abstract]
  24. Koivisto, P. V. I., Koivisto, U.-M., Miettinen, T. A., and Kontula, K. (1992) Arterioscler. Thromb. 12,584-592 [Abstract]
  25. Koivisto, P. V. I., Koivisto, U.-M., Kovanen, P. T., Gylling, H., Miettinen, T. A., and Kontula, K. (1993) Arterioscler. Thromb. 13,1680-1688 [Abstract]
  26. Kounnas, M. Z., Morris, R. E., Thompson, M. R., FitzGerald, D. J., Strickland, D. K., and Saelinger, C. B. (1992) J. Biol. Chem. 267,12420-12423 [Abstract/Free Full Text]
  27. Kounnas, M. Z., Chappell, D. A., Strickland, D. K., and Argraves, W. S. (1993) J. Biol. Chem. 268,14176-14181 [Abstract/Free Full Text]
  28. Laemmli, U. K. (1970) Nature 227,680-685 [Medline] [Order article via Infotrieve]
  29. Mac Lachlan, I., Nimpf, J., and Schneider, W. J. (1994) J. Biol. Chem. 269,24127-24132 [Abstract/Free Full Text]
  30. Nimpf, J., George, R., and Schneider, W. J. (1988) J. Lipid Res. 29,657-667 [Abstract]
  31. Nimpf, J., Radosavljevic, M. J., and Schneider, W. J. (1989) J. Biol. Chem. 264,1393-1398 [Abstract/Free Full Text]
  32. Nykjaer, A., Petersen, C. M., Moller, B., Jensen, P. H., Moestrup, S. K., Holtet, T. L., Etzerodt, M., Thogersen, H. C., Munch, M., Andreasen, P. A., and Gliemann, J. (1992) J. Biol. Chem. 267,14543-14546 [Abstract/Free Full Text]
  33. Nykjaer, A., Bengtsson-Olivecrona, G., Lookene, A., Moestrup, S. K., Petersen, C. M., Weber, W., Beisiegel, U., and Gliemann, J. (1993) J. Biol. Chem. 268,15048-15055 [Abstract/Free Full Text]
  34. Oka, K., Tzung, K.-W., Sullivan, M., Lindsay, E., Baldini, A., and Chan, L. (1994a) Genomics 20,298-300 [CrossRef][Medline] [Order article via Infotrieve]
  35. Oka, K., Ishimura-Oka, K., Chu, M., Sullivan, M., Krushkal, J., Li, W.-H., and Chan, L. (1994b) Eur. J. Biochem. 224,975-982 [Abstract]
  36. Orth, K., Madison, E. L., Gething, M.-J., Sambrook, J. F., and Herz, J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89,7422-7426 [Abstract]
  37. Saito, A., Pietromonaco, S., Loo, A. K.-C., and Farquhar, M. G. (1994) Proc. Natl. Acad. Sci. U. S. A. 91,9725-9729 [Abstract/Free Full Text]
  38. Sakai, J., Hoshino, A., Takahashi, S., Miura, Y., Ishii, H., Suzuki, H., Kawarabayasi, Y., and Yamamoto, T. (1994) J. Biol. Chem. 269,2173-2182 [Abstract/Free Full Text]
  39. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  40. Schneider, W. J. (1989) Biochim. Biophys. Acta 988,303-317 [Medline] [Order article via Infotrieve]
  41. Schneider, W. J. (1995) Curr. Opin. Lipidol. 6,92-96 [Medline] [Order article via Infotrieve]
  42. Schneider, W. J., and Nimpf J. (1993) Curr, Opin. Lipidol. 4,205-209
  43. Shen, X., Steyrer, E., Retzek, H., Sanders, E. J., and Schneider, W. J. (1993) Cell Tissue Res. 272,459-471 [Medline] [Order article via Infotrieve]
  44. Steyrer, E., Barber, D. L., and Schneider, W. J. (1990) J. Biol. Chem. 265,19575-19581 [Abstract/Free Full Text]
  45. Stifani, S., Barber, D. L., Nimpf, J., and Schneider, W. J. (1990a) Proc. Natl. Acad. Sci. U. S. A. 87,1955-1959 [Abstract]
  46. Stifani, S., Nimpf, J., and Schneider, W. J. (1990b) J. Biol. Chem. 265,882-888 [Abstract/Free Full Text]
  47. Strickland, D. K., Ashcom, J. D., Williams, S., Burgess, W. H., Migliorini, M., and Argraves, W. S. (1990) J. Biol. Chem. 265,17401-17404 [Abstract/Free Full Text]
  48. Strickland, D. K., Ashcom, J. D., Williams, S., Battey, F. D., Behre, E., McTigue, K., Battey, J. F., and Argraves, W. S. (1991) J. Biol. Chem. 266,13364-13369 [Abstract/Free Full Text]
  49. Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J., and Yamamoto, T. (1992) Proc. Natl. Acad. Sci. U. S. A. 89,9252-9256 [Abstract]
  50. Webb, J. C., Patel, D. D., Jones, M. D., Knight, B. L., and Soutar, A. K. (1994) Hum. Mol. Genet. 3,531-537 [Abstract]
  51. Wiborg Simonsen, C. A., W., Heegaard, C. W., Rasmussen, L. K., Ellgaard, L., Kjoller, L., Christensen, A., Etzerodt, M., and Andreasen, P. A. (1994) FEBS Lett. 354,279-283 [CrossRef][Medline] [Order article via Infotrieve]
  52. Willnow, T. E., Goldstein, J. L., Orth, K., Brown, M. S., and Herz. J. (1992) J. Biol. Chem. 267,26172-26180 [Abstract/Free Full Text]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.